More Evidence That Low-Dose Aspirin Ups Survival in CRC

This article originally appeared here.
Share this content:
More Evidence That Low-Dose Aspirin Ups Survival in CRC
More Evidence That Low-Dose Aspirin Ups Survival in CRC

FRIDAY, June 3, 2016 (HealthDay News) -- Colorectal cancer (CRC) patients who take low-dose aspirin may have better survival odds, according to a study published online May 31 the Journal of Clinical Oncology.

The findings are based on records from 23,162 Norwegian adults. They were all diagnosed with CRC between 2004 and 2011. More than one-quarter were prescribed daily low-dose aspirin for more than six months after their diagnosis. And, most had been taking aspirin before their diagnosis.

The researchers found that, overall, 67.1 percent of aspirin users were still alive after about three years. That compared with 57.7 percent of nonusers. After adjustment for factors such as age, severity of cancer, and whether patients were taking other particular medications, the survival benefit for aspirin users remained. The benefit was concentrated among patients who'd been taking aspirin before their diagnosis: They were 23 percent less likely to die of CRC -- and 14 percent less likely to die of any cause -- than patients who did not use aspirin at all.

"Aspirin use after the diagnosis of CRC is independently associated with improved CRC-specific survival and overall survival," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »